Mackenzie Financial’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $263K | Sell |
22,801
-1,755
| -7% | -$20.2K | ﹤0.01% | 1453 |
|
|
2025
Q1 | $368K | Buy |
24,556
+1,170
| +5% | +$17.5K | ﹤0.01% | 1310 |
|
|
2024
Q4 | $405K | Buy |
+23,386
| New | +$405K | ﹤0.01% | 1261 |
|
|
2017
Q1 | – | Sell |
-4,854
| Closed | -$583K | – | 646 |
|
|
2016
Q4 | $583K | Sell |
4,854
-1,000
| -17% | -$120K | ﹤0.01% | 495 |
|
|
2016
Q3 | $658K | Sell |
5,854
-23,676
| -80% | -$2.66M | ﹤0.01% | 466 |
|
|
2016
Q2 | $3.66M | Sell |
29,530
-3,070
| -9% | -$380K | 0.02% | 353 |
|
|
2016
Q1 | $3.67M | Buy |
32,600
+5,600
| +21% | +$630K | 0.03% | 281 |
|
|
2015
Q4 | $2.94M | Sell |
27,000
-4,000
| -13% | -$435K | 0.02% | 359 |
|
|
2015
Q3 | $3.09M | Buy |
31,000
+5,400
| +21% | +$539K | 0.02% | 342 |
|
|
2015
Q2 | $2.92M | Hold |
25,600
| – | – | 0.02% | 370 |
|
|
2015
Q1 | $2.68M | Buy |
+25,600
| New | +$2.68M | 0.01% | 382 |
|
|
2014
Q3 | – | Sell |
-4,176
| Closed | -$698K | – | 712 |
|
|
2014
Q2 | $698K | Sell |
4,176
-1,538
| -27% | -$257K | ﹤0.01% | 550 |
|
|
2014
Q1 | $1.13M | Sell |
5,714
-1,807
| -24% | -$359K | 0.01% | 466 |
|
|
2013
Q4 | $1.44M | Sell |
7,521
-3,100
| -29% | -$592K | 0.01% | 422 |
|
|
2013
Q3 | $1.8M | Sell |
10,621
-17,879
| -63% | -$3.03M | 0.01% | 383 |
|
|
2013
Q2 | $4.32M | Buy |
+28,500
| New | +$4.32M | 0.02% | 320 |
|